Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system

Bibliography

• FURCHGOTT RF, ZAWADZKI JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 288:373–376.
   PubMed Web of Science ®Google Scholar
• IGNARRO LJ, BUGA GM, WOOD KS, BYRNS RE, CHAUD-HURI G: Endothelium-derived relaxing factor pro-duced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA (1987) 84:9265–9269.
   PubMed Web of Science ®Google Scholar
• PALMER RM, FERRIGE AG, MONCADA S: Nitric oxide re-lease accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 327:524–526.
   PubMed Web of Science ®Google Scholar
• DUSTING GJ: Nitric oxide in cardiovascular disorders. Vasc. Res. (1995) 32:143–161.
   PubMed Web of Science ®Google Scholar
• CURTIS MJ, PABLA R: Nitric oxide supplementation or synthesis block-which is the better approach to treat-ment of heart disease? Trends Pharmacol. Sci. (1997) 18:239–244.
   Google Scholar
• STOCLET JC, FLEMING I, GRAY G et al: Nitric oxide and entotoxemia. Circulation (1993) 87 (Suppl. V):77–80.
   Google Scholar
• JOHNSON ML, BILLIAR TR: Roles of nitric oxide in surgi-cal infection and sepsis. World J. Surg. (1998) 22:187–196.
   PubMed Web of Science ®Google Scholar
• MONCADA S, HIGGS A, FURCHGOTT R: International Union of Pharmacology nomenclature in nitric oxide research. Pharmacol. Rev. (1997) 49:137–142.
   PubMed Web of Science ®Google Scholar
• FORSTERMANN U, BOISSEL JP, KLEINERT H: Expres-sional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. (1998) 12:773–790.
   PubMed Web of Science ®Google Scholar
• CHRISTOPHERSON KS, BREDT DS: Nitric oxide in excit-able tissues: physiological roles and disease. J. Clin. In-vest. (1997) 100:2424–2429.
   PubMed Web of Science ®Google Scholar
• MICHEL T, FERON O: Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. (1997) 100:2146–2152.
   Google Scholar
• POU S, POU WS, BREDT DS, SNYDER SH, ROSEN GM: Generation of superoxide by purified brain nitric ox-ide synthase. J. Biol. Chem. (1992) 267:24173–24176.
   PubMed Web of Science ®Google Scholar
• XIA Y, ZWEIER JL: Superoxide and peroxynitrite gen-eration from inducible nitric oxide synthase in macro-phages. Proc. Natl. Acad. Sci. USA (1997) 94:6954–6958.
   PubMed Web of Science ®Google Scholar
• MAYER B, PFEIFFER S, SCHRAMMEL A et al.: A new path-way of nitric oxide/cyclic GMP signaling involving, S-n-itrosoglutathione. J. Biol. Chem. (1998) 273:3264–3270.
   PubMed Web of Science ®Google Scholar
• VASQUEZ-VIVAR J, KALYANARAMAN B, MARTASEK P et al.: Superoxide generation by endothelial nitric oxide synthase: the influence of co-factors. Proc. Natl. Acad. Sci. USA (1998) 95:9220–9225.
   PubMed Web of Science ®Google Scholar
• WASCHER TC, POSCH K, WALLNER S et al.: Vascular ef-fects of t-arginine: anything beyond a substrate for the NO-synthase? Biochem. Biophys. Res. Commun. (1997) 234:35–38.
   PubMed Web of Science ®Google Scholar
• WIEMER G, LINZ W, HATRIK S, SCHOLKENS BA, MALINSKIT: Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats. Hypertension (1997) 30:1183–1190.
   PubMed Web of Science ®Google Scholar
• VALLANCE P, LEONE A, CALVER A, COLLIER J, MONCADA S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet (1992) 339:572–575.
   PubMed Web of Science ®Google Scholar
• MACALLISTER RJ, FICKLING SA, WHITLEY GS, VALLANCE P: Metabolism of methylarginines by human vascula-ture; implications for the regulation of nitric oxide synthesis. Br. J. Pharmacol (1994) 112:43–48.
   PubMed Web of Science ®Google Scholar
• MATSUOKA H, ITOH S, KIMOTO M et al.: Asymmetrical dimethylarginine, an endogenous nitric oxide syn-thase inhibitor, in experimental hypertension. Hyper-tension (1997) 29:242–247.
   Google Scholar
• MULSCH A, VANIN A, MORDVINTCEV P, HAUSCHILDT S, BUSSE R: NO accounts completely for the oxygenated nitrogen species generated by enzymic t-arginine oxy-genation. Biochem. J. (1992) 288:597–603.
   PubMed Web of Science ®Google Scholar
• XIA Y, ZWEIER JL: Direct measurement of nitric oxide generation from nitric oxide synthase. Proc. Natl. Acad. Sci. USA (1997) 94:12705–12710.
   PubMed Web of Science ®Google Scholar
• AL-SA'DONI HH, MEGSON IL, BISLAND S, BUTLER AR, FLITNEY FW: Neocuproine, a selective Culp chelator, and the relaxation of rat vascular smooth muscle by S-nitrosothiols. Br. J. Pharmacol (1997) 121:1047–1050.
   PubMed Web of Science ®Google Scholar
• STAMLER JS, SINGEL DJ, LOSCALZO J: Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 258:1898–1902.
   PubMed Web of Science ®Google Scholar
• JIA L, BONAVENTURA C, BONAVENTURA J, STAMLER JS: S-nitrosohaemoglobin: a dynamic activity of blood in-volved in vascular control. Nature (1996) 380:221–226.
   PubMed Web of Science ®Google Scholar
• HECKER M, BOESE M, SCHINI-KERTH VB, MULSCH A, BUSSE R: Characterization of the stable t-arginine--derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-t-arginine-nitric oxide adduct. Proc. Natl. Acad. Sci. USA (1995) 92:4671–4675.
   PubMed Web of Science ®Google Scholar
• MORO MA, DARLEY-USMAR VM, LIZASOAIN I et al: Theformation of nitric oxide donors from peroxynitrite. Br. J. Pharmacol (1995) 116:1999–2004.
   PubMed Web of Science ®Google Scholar
• BEASLEY D, MCGUIGGIN M: Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J. Exp. Med. (1994) 179:71–80.
   PubMed Web of Science ®Google Scholar
• WU CC, SZABO C, CHEN SJ, THIEMERMANN C, VANE JR: Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin. Biochem. Biophys. Res. Commun. (1994) 201:436–442.
   PubMed Web of Science ®Google Scholar
• STAMLER JS: Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell (1994) 78:931–936.
   PubMed Web of Science ®Google Scholar
• MONCADA S, PALMER RM, HIGGS EA: Nitric oxide:physiology, pathophysiology, and pharmacology. Pharmacol. Rev. (1991) 43:109–142.
   PubMed Web of Science ®Google Scholar
• STOCLET JC, ANDRIANTSITOHAINA R, KLESCHYOV A, MULLER B: Nitric oxide and cGMP in regulation of arte-rial tone. Trends Cardiovasc. Med. (1998) 8:14–19.
   PubMed Web of Science ®Google Scholar
• HOBBS AJ: Soluble guanylate cyclase: the forgotten sib-ling. Trends Pharmacol. Sci. (1997) 18:484–491.
   PubMed Web of Science ®Google Scholar
• SAEKI T, YASUTAKA T: Phosphodiesterase 5 inhibitors in development for cardiovascular therapy. Exp. Opin. Invest. Drugs (1996) 5:1477–1486.
   Google Scholar
• LI H, LIU JP, ROBINSON PJ: Multiple substrates for cGMP-dependent protein kinase from bovine aortic smooth muscle: purification of P1. j Vasc. Res. (1996) 33:99–110.
   PubMed Web of Science ®Google Scholar
• MORO MA, DARLEY-USMAR VM, GOODWIN DA et al:Paradoxical fate and biological action of peroxynitrite on human platelets. Proc. Natl. Acad. Sci. USA (1994) 91:6702–6706.
   PubMed Web of Science ®Google Scholar
• ISCHIROPOULOS H: Biological tyrosine nitration: a pa-thophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. (1998) 356:1–11.
   PubMed Web of Science ®Google Scholar
• SCORZA G, MINETTI M: One-electron oxidation path-way of thiols by peroxynitrite in biological fluids: bi-carbonate and ascorbate promote the formation of albumin disulphide dimers in human blood plasma. Biochem. J. (1998) 329:405–413.
   PubMed Web of Science ®Google Scholar
• BOUTON C, HIRLING H, DRAPIER JC: Redox modulation of iron regulatory proteins by peroxynitrite. J. Biol. Chem. (1997) 272:19969–19975.
   PubMed Web of Science ®Google Scholar
• BECKMAN JS, KOPPENOL WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. (1996) 271:C1424–C1437.
   PubMed Web of Science ®Google Scholar
• ARNAL JF, CLAMENS S, PECHET C et aLEthinylestradiol does not enhance the expression of nitric oxide syn-thase in bovine endothelial cells but increases the re-lease of bioactive nitric oxide by inhibiting superoxide anion production. Proc. Natl. Acad. Sci. USA (1996) 93:4108–4113.
   PubMed Web of Science ®Google Scholar
• KAUSER K, RUBANYI GM: Potential cellular signalingmechanisms mediating upregulation of endothelial nitric oxide production by estrogen. J. Vasc. Res. (1997) 34:229–236.
   PubMed Web of Science ®Google Scholar
• CAULIN-GLASER T, GARCIA-CARDENA G, SARREL P, SESSA WC, BENDER JR: 17 Beta-estradiol regulation of human endothelial cell basal nitric oxide release, in-dependent of cytosolic Ca2+ mobilization. Circ. Res. (1997) 81:885–892.
   PubMed Web of Science ®Google Scholar
• SHEEHY AM, BURSON MA, BLACK SM: Nitric oxide expo-sure inhibits endothelial NOS activity but not gene ex-pression: a role for superoxide. Am. J. Physiol. (1998) 2741833–L841.
   Google Scholar
• PAGANO PJ, ITO Y, TORNHEIM K et al.: An NADPH oxi-dase superoxide-generating system in the rabbit aorta. Am. J. Physiol (1995) 268:H2274–H2280.
   PubMed Web of Science ®Google Scholar
• WANG HD, PAGANO PJ, DU Y et al.: Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ. Res. (1998) 82:810–818.
   PubMed Web of Science ®Google Scholar
• CASTRO L, RODRIGUEZ M, RADI R: Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. (1994) 269:29409–29415.
   PubMed Web of Science ®Google Scholar
• RADI R, RODRIGUEZ M, CASTRO L, TELLERI R: Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. (1994) 308:89–95.
   PubMed Web of Science ®Google Scholar
• NGUYEN T, BRUNSON D, CRESPI CL etal: DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA (1992) 89:3030–3034.
   PubMed Web of Science ®Google Scholar
• LE RHUN Y, KIRKLAND JB, SHAH GM: Cellular responses to DNA damage in the absence of Poly(ADP-ribose) po-lymerase. Biochem. Biophys. Res. Commun. (1998) 245:1–10.
   PubMed Web of Science ®Google Scholar
• SZABO C, DAWSON VL: Role of poly(ADP-ribose) syn-thetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci. (1998) 19:287–298.
   PubMed Web of Science ®Google Scholar
• LE PAGE C, SANCEAU J, DRAPIER JC, WIETZERBIN J: In-hibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem. Biophys. Res. Com-mun. (1998) 243:451–457.
   PubMed Web of Science ®Google Scholar
• NOSSULI TO, HAYWARD R, JENSEN D, SCALIA R, LEFERAM: Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am. J. Physiol. (1998) 275:H509–H519.
   PubMed Web of Science ®Google Scholar
• STAMLER JS, JARAKI O, OSBORNE J etal.: Nitric oxide cir-culates in mammalian plasma primarily as an, S- ni-troso adduct of serum albumin. Proc. Nati Acad. Sci. USA (1992) 89:7674–7677.
   Google Scholar
• SCHARFSTEIN JS, KEANEY JF, SLIVKA A et al: In vivotransfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J. Clin. Invest. (1994) 94:1432–1439.
   PubMed Web of Science ®Google Scholar
• WILLIAMS DL: S-nitrosothiols and role of metal ions indecomposition to nitric oxide. Methods Enzymol. (1996) 268:299–308.
   PubMed Web of Science ®Google Scholar
• HOGG N, SINGH RJ, KONOREV E, JOSEPH J, KALYANARA-MAN B: S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochem. J. (1997) 323:477–481.
   PubMed Web of Science ®Google Scholar
• ALERYANI S, MILO E, ROSE Y, KOSTKA P: Superoxide-mediated decomposition of biological S-nitrosothiols. J. Biol. Chem. (1998) 273:6041–6045.
   PubMed Web of Science ®Google Scholar
• JOURD'HEUIL D, MAI CT, LAROUX FS, WINK DA, GRISHAM MB: The reaction of S-nitrosothiols with su-peroxide. Biochem. Biophys. Res. Commun. (1998) 246:525–530.
   PubMed Web of Science ®Google Scholar
• GOW AJ, STAMLER JS: Reactions between nitric oxideand haemoglobin under physiological conditions. Na-ture (1998) 391:169–173.
   PubMed Web of Science ®Google Scholar
• MALMROS C, BLOMQUIST S, DAHM P, MARTENSSON L,THORNE J: Nitric oxide inhalation decreases pulmo-nary platelet and neutrophil sequestration during ex-tracorporeal circulation in the pig. Crit. Care Med. (1996) 24:845–849.
   PubMedGoogle Scholar
• TRONCY E, FRANCOEUR M, SALAZKIN I et al: Extra-pulmonary effects of inhaled nitric oxide in swine with and without phenylephrine. Br. J. Anaesth. (1997) 79:631–640.
   PubMed Web of Science ®Google Scholar
• FOX-ROBICHAUD A, PAYNE D, HASAN SU et al.: Inhaled NO as a viable antiadhesive therapy for ische-mia/reperfusion injury of distal microvascular beds. J. Clin. Invest. (1998) 101:2497–2505.
   PubMed Web of Science ®Google Scholar
• BOLOTINA VM, NAJIBI S, PALACINO JJ, PAGANO PJ, CO-HEN RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature (1994) 368:850–853.
   PubMed Web of Science ®Google Scholar
• XU L, EU JP, MEISSNER G, STAMLER JS: Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science (1998) 279:234–237.
   PubMed Web of Science ®Google Scholar
• MATSUDA T, BATES JN, LEWIS SJ, ABBOUD FM, CHAPLEAU MW: Modulation of baroreceptor activity by nitric oxide and S-nitrosocysteine. Circ. Res. (1995) 76:426–433.
   PubMed Web of Science ®Google Scholar
• DARLEY-USMAR VM, MCANDREW J, PATEL R et al.: Bio-logical and pathological implications of nitration and nitrosation reactions. In: Abstracts from Biological Chem-istry and Cellular Targets of Nitric Oxide. Graz, Austria (1998):0–3.
   Google Scholar
• HENDERSON SA, LEE PH, AEBERHARD EE etal.: Nitric ox-ide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide. J. Biol. Chem. (1994) 269:25239–24242.
   Google Scholar
• GOPALAKRISHNA R, CHEN ZH, GUNDIMEDA U: Nitricoxide and nitric oxide-generating agents induce a re-versible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. (1993) 268:27180–27185.
   PubMed Web of Science ®Google Scholar
• CASELLI A, CAMICI G, MANAO G et al.: Nitric oxidecauses inactivation of the low molecular weight phos-photyrosine protein phosphatase. J. Biol. Chem. (1994) 269:24878–24882.
   PubMed Web of Science ®Google Scholar
• KIM YM, TALANIAN RV, BILLIAR TR: Nitric oxide inhibitsapoptosis by preventing increases in caspase-3-like ac-tivity via two distinct mechanisms. J. Biol. Chem. (1997) 272:31138–31148.
   PubMed Web of Science ®Google Scholar
• COHEN RA, PLANE F, NAJIBI S et al.: Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc. Natl. Acad. Sci. USA (1997) 94:4193–4198.
   PubMed Web of Science ®Google Scholar
• MISTRY DK, GARLAND CJ: Nitric oxide (NO) induces ac-tivation of large conductance Ca2±-dependent It chan-nels (BKca) in smooth muscle cells isolated from the rat mesenteric artery. Br. J. Pharmacol. (1998) 124:1131–1140.
   PubMed Web of Science ®Google Scholar
• BRUNE B, VON KNETHEN A, SANDAU KB: Nitric oxideand its role in apoptosis. Eur. J. Pharmacol. (1998) 351:261–272.
   PubMed Web of Science ®Google Scholar
• MALYSHEV IY, MALUGIN AV, GOLUBEVA LY et al.: Nitricoxide donor induces HSP70 accumulation in the heart and in cultured cells. FEBS Lett. (1996) 391:21–23.
   PubMed Web of Science ®Google Scholar
• KIM YM, DE VERA ME, WATKINS SC, BILLIAR TR: Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-a-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. (1997) 272:1402–1411.
   PubMed Web of Science ®Google Scholar
• MEGSON IL, GREIG IR, GRAY GA, WEBB DJ, BUTLER AR: Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: po-tential as a slow release nitric oxide donor drug. Br. J. Pharmacol. (1997) 122:1617–1624.
   PubMed Web of Science ®Google Scholar
• HENRY Y, LEPOIVRE M, DRAPIER JC et al: EPR charac-terization of molecular targets for NO in mammalian cells and organelles. FASEB J (1993) 7:1124–1134.
   PubMed Web of Science ®Google Scholar
• MULSCH A, MORDVINTCEV PI, VANIN AF, BUSSE R: For-mation and release of dinitrosyl iron complexes by en-dothelial cells. Biochem. Biophys. Res. Commun. (1993) 196:1303–1308.
   PubMed Web of Science ®Google Scholar
• MULLER B, KLESCHYOV AL, STOCLET JC: Evidence for N-acetylcysteine-sensitive nitric oxide storage as dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta. Br. J. Pharmacol. (1996) 119:1281–1285.
   PubMed Web of Science ®Google Scholar
• KLESCHYOV AL, MULLER B, STOCLET JC: Nitric oxide (NO) store as dinitrosyl-iron complexes in lipopolysaccharide-treated rat isolated aorta: localiza-tion and mechanisms of formation. Br. J. Pharmacol. (1997) 120:90P (Abstract).
   Google Scholar
• KLESCHYOV AL, MULLER B, SCHOTT C, STOCLET JC: Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta. Br. J. Phar-macol. (1998) 124:623–626.
   PubMed Web of Science ®Google Scholar
• MULSCH A, MORDVINTCEV P, VANIN AF, BUSSE R: The potent vasodilating and guanylyl cyclase activating dinitrosyl-iron(I) complex is stored in a protein- bound form in vascular tissue and is released by thiols. FEBS Lett. (1991) 294:252–256.
   PubMed Web of Science ®Google Scholar
• BOESE M, MORDVINTCEV PI, VANIN AF, BUSSE R, MULSCH A: S-nitrosation of serum albumin by dinitrosyl-iron complex. J. Biol. Chem. (1995) 270:29244–29249.
   PubMed Web of Science ®Google Scholar
• VANIN AF, KLESCHYOV AL: EPR detection and biologi-cal implications of nitrosyl non-heme iron com-plexes. In: Nitric Oxide in Transplant Rejection and Antitumour Defense. Lukiewicz SJ, Zweier JL (Eds.), Kluwer Academic Publishers, Norwell, MA (1998): (In Press.)
   Google Scholar
• MULLER B, KLESCHYOV AL, MALBLANC S, STOCLET JC: Nitric oxide-related cyclic GMP-independent relaxing effect of N-acetylcysteine in lipopolysaccharide-treated rat aorta. Br. J. Pharmacol. (1998) 123:1221–1229.
   PubMed Web of Science ®Google Scholar
• KLESCHYOV AL, MORDVINTCEV PI, VANIN AF: Role of nitric oxide and iron in hypotensive action of nitrosyl iron complexes with various anion ligands. Studia Bio-phys. (1985) 105:93–102.
   Google Scholar
• GORBUNOV NV, YALOWICH JC, GADDAM A et al.: Nitric oxide prevents oxidative damage produced by tert-butyl hydroperoxide in erythroleukemia cells via ni-trosylation of heme and non-heme iron. Electron par-amagnetic resonance evidence. J. Biol. Chem. (1997) 272:12328–12341.
   Google Scholar